ESR1 and breast cancer: However, activated PPARβ/δ did not exert similar effects on ER- breast cancer cells MDA-MB-231 and BT-20, revealing that the pro-proliferative and pro-angiogenic effects of PPARβ/δ on breast cancer are dependent on ER [143].